KRYS

Krystal Biotech (KRYS)

About Krystal Biotech (KRYS)

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Details

Daily high

$278.06

Daily low

$271.30

Price at open

$275.17

52 Week High

$298.30

52 Week Low

$122.80

Market cap

8.0B

Dividend yield

0.00%

Volume

367,722

Avg. volume

266,141

P/E ratio

39.84

Krystal Biotech News